Immune Thrombocytopenia (ITP) Immune-Genetic Assessment

IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01196884

Acronym

UNIT

Enrollment

190

Registered

2010-09-09

Start date

2010-09-30

Completion date

Unknown

Last updated

2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombocytopenia

Keywords

Patients with primary Immune Thrombocytopenia (ITP)

Brief summary

Primary ITP has wide heterogenous biology, presentation and response to therapy. The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Adult patients with primary ITP

Exclusion criteria

* Secondary ITP

Countries

Italy

Contacts

Primary ContactFrancesco Zaja, MD

zaja.francesco@aoud.sanita.fvg.it+39 0432 559604

Outcome results